In order to investigate the involvement of tumor endothelial marker 1 (TEM1) and matrix metalloproteinase 2 (MMP-2) in the development of uterine sarcoma, immunohistochemistry analysis is also used. This evidence concerns the gene MMP2 and uterine corpus sarcoma.